New drug can successfully treat patients typically resistant to high blood pressure treatment

Glass laboratory flasks on light table

A new drug called Baxdrostat has been shown to significantly reduce high blood pressure (hypertension) in patients who may not respond to current treatments for the condition, according to results from a phase II trial led jointly by a Queen Mary University of London researcher and colleagues at CinCor Pharma, U.S..

‘Quordle’ today: Here are the answers and hints for November 8

Previous article

Study highlights the need for early and timely diagnosis of type 1 diabetes in children and adolescents

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations